NCT00151294View on ClinicalTrials.gov

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

PHASE4TerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

October 31, 2006

Conditions

DepressionMultiple Sclerosis

Interventions

DRUG

escitalopram oxalate antidepressant

Trial Locations (1)

10605

NewYork Presbyterian Hospital, White Plains

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER